Literature DB >> 16235781

Hypertension and peripheral arterial disease.

Jeffrey W Olin1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16235781     DOI: 10.1191/1358863x05vm591xx

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


× No keyword cloud information.
  6 in total

Review 1.  Peripheral artery disease. Part 2: medical and endovascular treatment.

Authors:  Mitchell D Weinberg; Joe F Lau; Kenneth Rosenfield; Jeffrey W Olin
Journal:  Nat Rev Cardiol       Date:  2011-06-14       Impact factor: 32.419

2.  Peripheral artery disease: current insight into the disease and its diagnosis and management.

Authors:  Jeffrey W Olin; Brett A Sealove
Journal:  Mayo Clin Proc       Date:  2010-07       Impact factor: 7.616

Review 3.  Overview of classification systems in peripheral artery disease.

Authors:  Rulon L Hardman; Omid Jazaeri; J Yi; M Smith; Rajan Gupta
Journal:  Semin Intervent Radiol       Date:  2014-12       Impact factor: 1.513

Review 4.  Glutathione-S-transferase M1 and T1 null genotypes are associated with hypertension risk: a systematic review and meta-analysis of 12 studies.

Authors:  Saeid Eslami; Amirhossein Sahebkar
Journal:  Curr Hypertens Rep       Date:  2014-06       Impact factor: 5.369

5.  Pneumoconiosis increases the risk of peripheral arterial disease: a nationwide population-based study.

Authors:  Chih-Hao Shen; Te-Yu Lin; Wen-Yen Huang; Hsuan-Ju Chen; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

6.  Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation in type 2 Diabetes (BARI 2D) Trial.

Authors:  Andrew D Althouse; J Dawn Abbott; Alan D Forker; Marnie Bertolet; Emma Barinas-Mitchell; Rebecca C Thurston; Suresh Mulukutla; Victor Aboyans; Maria Mori Brooks
Journal:  Diabetes Care       Date:  2014-03-04       Impact factor: 19.112

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.